In that group, GLP-1 use was associated with fewer addiction-related emergencies and serious health consequences
adults without diabetes used a GLP-1 (drug) in 2022, wrote the research team led by Michelle Dowsey, an epidemiologist with the University of Melbourne in Australia.GLP-1 drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food.Initially approved to control diabetes, the drugs effectiveness at helping people lose weight led to their later approval for that purpose as well.For this study, researchers analyzed U.S
Among the common side effects these drugs share are gastrointestinal ones, such as nausea, vomiting, constipation, diarrhea, and stomach or abdominal pain
Statistically significant
However, it is an invasive procedure with associated surgical risks, a longer recovery period, and requires lifelong nutritional and lifestyle changes
Altammar KA (2023) A review on nanoparticles: characteristics, synthesis, applications, and challenges